We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Cedars-Sinai Hospital to Use FitBit to Measure Patient Mobility

By HospiMedica International staff writers
Posted on 03 Feb 2016
Cedars-Sinai Medical Center (Los Angeles, CA, USA) is conducting a study to see if using an activity bracelet could help assess if oncologic patients are active enough for chemotherapy.

The short, two-week trial will enroll 30 patients in advanced stages of cancer who are ambulatory, over 18, and have access to an internet-connected smartphone. More...
The trial will mainly be a feasibility study, seeing how effective a Fitbit (San Francisco, CA, USA) activity bracelet, as well as questionnaires, are at monitoring the target population. All 30 patients will be given Fitbit Charge HR device and will be asked to wear it at all times, other than in the bath and other times the tracker would be submerged.

The patients will also fill out questionnaires at two oncologist visits during the trial period, and again at a six month follow-up. Researchers will also review mortality and hospitalization for the subjects, as well as whether they wore the device as directed. They will also examine whether the combination of the Fitbit device and the patient-reported-outcome questionnaires can help physicians screen patients for subjective measures such as fatigue, distress, pain, and trouble sleeping, which patients can tend to under-report.

“What we know is that individuals who are up and about tend to be more able to tolerate chemotherapy and have a greater potential for benefitting from it,” said lead investigator Arvind Shinde, MD, of the departments of supportive care medicine, hematology, and oncology. “People who are spending more time in bed usually get harmed by the treatment we give, even if the cancer is responsive to the treatment.”

“A 30-patient study is not enough to give us all the data we need; the two-week trial is something of a dry run to get the kinks of data collection ironed out. The next step will be to do a larger study across multiple tumor types and follow people longitudinally for a much longer period of time,” added Dr. Shinde. “We can see how they do as they progress through their treatments, follow their ups and downs. We’ll be able to get changes over baseline and create a better algorithm for this assessment.”

The Fitbit Charge HR is an activity wrist band that offers continuous heart rate monitoring for better estimation of daily activity, tracking workouts, and monitoring resting heart rate and sleep quality. The advanced tracking records daily steps and calories by day and sleep by night, switching between modes based on movement and heart rate data. The device is linked by an app to a smartphone, allowing real time monitoring of daily data. The Charge HR is available in a range of colors, including black, plum, blue, teal, and tangerine.

Related Links:

Cedars-Sinai Medical Center
Fitbit



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Tracheostomy Tube
Portex BLUselect
New
Pressure Transducer
TruWave
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: the deep tissue in vivo sound printing (DISP) platform, which combines ultrasound with low-temperature–sensitive liposomes loaded with crosslinking agents (Photo courtesy of Elham Davoodi and Wei Gao/Caltech)

New Ultrasound-Guided 3D Printing Technique to Help Fabricate Medical Implants

3D bioprinting technologies hold considerable promise for advancing modern medicine by enabling the production of customized implants, intricate medical devices, and engineered tissues designed to meet... Read more

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.